Clinical Trial Update: DaTSCAN Imaging in Aging and Neurodegenerative Disease [Phase 4]

View source ↗

Summary

An update on a Phase 4 clinical trial evaluating DaTSCAN imaging in aging and neurodegenerative diseases, currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Dementia
• Parkinsonism
• Rem Sleep Behavior Disorder

Drugs mentioned

• DaTscan (ioflupane)

Snippet

Sponsor: Mayo Clinic | Conditions: Dementia, Parkinsonism | Phase 4 | Status: ENROLLING_BY_INVITATION